2C53.0

ICD-11 MMS 2026-01

Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum

Exclusions from above levels

  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C53.1 – Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum
  • 2C53.Y – Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
  • 2C53.Z – Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified

Foundation entity

Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum – http://id.who.int/icd/entity/680151582

Allowed postcoordination axes

Part of: 2C53: Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum › 02: Neoplasms